VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Vaccine Mechanisms
Vaximmutordb
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From Apr 01, 2020 To Apr 10, 2020:

Brucella (Brucellosis)

  1. Gupta T, Rawat M, Kumar B, Varshney R, Chakravarti S, Qureshi S. Evaluation of real-time PCR as an alternative for potency testing of <i>Brucella abortus</i> vaccines Animal biotechnology :1-11 2020 [PMID: 32241210]
  2. Huang J, Pan C, Sun P, Feng E, Wu J, Zhu L, Wang H. Application of an <i>O</i>-Linked Glycosylation System in <i>Yersinia enterocolitica</i> Serotype O:9 to Generate a New Candidate Vaccine against <i>Brucella abortus</i> Microorganisms 8(3) 2020 [PMID: 32244903]
  3. Hassan H, Salami A, Nehme N, Hakeem RA, Hage JE, Awada R. Prevalence and prevention of brucellosis in cattle in Lebanon Veterinary world 13(2):364-371 2020 [PMID: 32255981]
  4. Shome R, Nagalingam M, Priya R, Sahay S, Kalleshamurthy T, Sharma A, Bambal RG, Rahman H, Shome BR. Perceptions and preparedness of veterinarians to combat brucellosis through Brucellosis Control Programme in India Veterinary world 13(2):222-230 2020 [PMID: 32255962]

Clostridium botulinum toxin (Botulism)

  1. Otaka DY, Barbosa JD, de Souza LA, Moreira C Jr, Ferreira MRA, Donassolo RA, Conceição FR, Salvarani FM. Recombinant vaccine against botulism in buffaloes: Evaluation of the humoral immune response over 12 months Anaerobe :102201 2020 [PMID: 32247696]

Coronavirus

  1. Deming ME, Chen WH. COVID-19 and Lessons to be Learned from Prior Coronavirus Outbreaks Annals of the American Thoracic Society 2020 [PMID: 32267164]
  2. Chen L, Hao G. The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease Cardiovascular research 2020 [PMID: 32267499]
  3. Okba NMA, Müller MA, Li W, Wang C, GeurtsvanKessel CH, Corman VM, Lamers MM, Sikkema RS, de Bruin E, Chandler FD, Yazdanpanah Y, Le Hingrat Q, Descamps D, Houhou-Fidouh N, Reusken CBEM, Bosch BJ, Drosten C, Koopmans MPG, Haagmans BL. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients Emerging infectious diseases 26(7) 2020 [PMID: 32267220]
  4. Rokni M, Ghasemi V, Tavakoli Z. Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS Reviews in medical virology 2020 [PMID: 32267987]
  5. Gbinigie K, Frie K. Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review BJGP open 2020 [PMID: 32265182]
  6. Ciotti M, Angeletti S, Minieri M, Giovannetti M, Benvenuto D, Pascarella S, Sagnelli C, Bianchi M, Bernardini S, Ciccozzi M. COVID-19 Outbreak: An Overview Chemotherapy :1-9 2020 [PMID: 32259829]
  7. Qian X, Ren R, Wang Y, Guo Y, Fang J, Wu ZD, Liu PL, Han TR. Fighting against the common enemy of COVID-19: a practice of building a community with a shared future for mankind Infectious diseases of poverty 9(1):34 2020 [PMID: 32264957]
  8. Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection Journal of biological regulators and homeostatic agents 34(2) 2020 [PMID: 32253888]
  9. Li K, Li Z, Wohlford-Lenane C, Meyerholz DK, Channappanavar R, An D, Perlman S, McCray PB Jr, He B. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection mBio 11(2) 2020 [PMID: 32265331]
  10. Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Effectiveness of convalescent plasma therapy in severe COVID-19 patients Proceedings of the National Academy of Sciences of the United States of America 2020 [PMID: 32253318]
  11. Ohe M, Shida H, Jodo S, Kusunoki Y, Seki M, Furuya K, Goudarzi H. Macrolide treatment for COVID-19: Will this be the way forward? Bioscience trends 2020 [PMID: 32249257]
  12. Kim YI, Kim SG, Kim SM, Kim EH, Park SJ, Yu KM, Chang JH, Kim EJ, Lee S, Casel MAB, Um J, Song MS, Jeong HW, Lai VD, Kim Y, Chin BS, Park JS, Chung KH, Foo SS, Poo H, Mo IP, Lee OJ, Webby RJ, Jung JU, Choi YK. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets Cell host & microbe 2020 [PMID: 32259477]
  13. Bastani P, Bahrami MA. COVID-19 Related Misinformation on Social Media: A Qualitative Study from Iran Journal of medical Internet research 2020 [PMID: 32250961]
  14. Yu X, Yang R. COVID-19 transmission through asymptomatic carriers is a challenge to containment Influenza and other respiratory viruses 2020 [PMID: 32246886]
  15. Monto AS, DeJonge P, Callear AP, Bazzi LA, Capriola S, Malosh RE, Martin ET, Petrie JG. Coronavirus occurrence and transmission over 8 years in the HIVE cohort of households in Michigan The Journal of infectious diseases 2020 [PMID: 32246136]
  16. Moghadas SM, Shoukat A, Fitzpatrick MC, Wells CR, Sah P, Pandey A, Sachs JD, Wang Z, Meyers LA, Singer BH, Galvani AP. Projecting hospital utilization during the COVID-19 outbreaks in the United States Proceedings of the National Academy of Sciences of the United States of America 2020 [PMID: 32245814]
  17. Cohen J. Infect volunteers to speed a coronavirus vaccine? Science (New York, N.Y.) 368(6486):16 2020 [PMID: 32241929]
  18. Cohen J. Vaccine designers take first shots at COVID-19 Science (New York, N.Y.) 368(6486):14-16 2020 [PMID: 32241928]
  19. Dong Y, Wang L, Burgner DP, Miller JE, Song Y, Ren X, Li Z, Xing Y, Ma J, Sawyer SM, Patton GC. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017 BMJ (Clinical research ed.) 369:m1043 2020 [PMID: 32241761]
  20. Ofstead CL, Hopkins KM, Binnicker MJ, Poland GA. Potential impact of contaminated bronchoscopes on novel coronavirus disease (COVID-19) patients Infection control and hospital epidemiology :1-10 2020 [PMID: 32238217]
  21. Ceribelli A, Motta F, De Santis M, Ansari AA, Ridgway WM, Gershwin ME, Selmi C. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy Journal of autoimmunity :102442 2020 [PMID: 32253068]
  22. Khan SA, Zia K, Ashraf S, Uddin R, Ul-Haq Z. Identification of Chymotrypsin-like Protease Inhibitors of SARS-CoV-2 <i>Via</i> Integrated Computational Approach Journal of biomolecular structure & dynamics :1-13 2020 [PMID: 32238094]
  23. de Lusignan S, Lopez Bernal J, Zambon M, Akinyemi O, Amirthalingam G, Andrews N, Borrow R, Byford R, Charlett A, Dabrera G, Ellis J, Elliot AJ, Feher M, Ferreira F, Krajenbrink E, Leach J, Linley E, Liyanage H, Okusi C, Ramsay M, Smith G, Sherlock J, Thomas N, Tripathy M, Williams J, Howsam G, Joy M, Hobbs R. Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England JMIR public health and surveillance 6(2):e18606 2020 [PMID: 32240095]
  24. Zhang J, Litvinova M, Wang W, Wang Y, Deng X, Chen X, Li M, Zheng W, Yi L, Chen X, Wu Q, Liang Y, Wang X, Yang J, Sun K, Longini IM Jr, Halloran ME, Wu P, Cowling BJ, Merler S, Viboud C, Vespignani A, Ajelli M, Yu H. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study The Lancet. Infectious diseases 2020 [PMID: 32247326]
  25. Gao X, Zhao D, Zhou P, Zhang L, Li M, Li W, Zhang Y, Wang Y, Liu X. Characterization, Pathogenicity and Protective efficacy of a Cell Culture-Derived Porcine Deltacoronavirus Virus research :197955 2020 [PMID: 32247757]
  26. Kim E, Erdos G, Huang S, Kenniston TW, Balmert SC, Carey CD, Raj VS, Epperly MW, Klimstra WB, Haagmans BL, Korkmaz E, Falo LD Jr, Gambotto A. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development EBioMedicine :102743 2020 [PMID: 32249203]
  27. Verelst F, Kuylen E, Beutels P. Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 25(13) 2020 [PMID: 32265003]
  28. Xie M, Chen Q. Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2020 [PMID: 32247050]
  29. Lu CC, Chen MY, Chang YL. Potential therapeutic agents against COVID-19: What we know so far Journal of the Chinese Medical Association : JCMA 2020 [PMID: 32243270]
  30. Cagliani R, Forni D, Clerici M, Sironi M. Computational inference of selection underlying the evolution of the novel coronavirus, SARS-CoV-2 Journal of virology 2020 [PMID: 32238584]
  31. Caly L, Druce J, Roberts J, Bond K, Tran T, Kostecki R, Yoga Y, Naughton W, Taiaroa G, Seemann T, Schultz MB, Howden BP, Korman TM, Lewin SR, Williamson DA, Catton MG. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia The Medical journal of Australia 2020 [PMID: 32237278]
  32. Reina J. [Remdesivir, the antiviral hope against SARS-CoV-2] Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 2020 [PMID: 32239125]
  33. Shi Y, Wang N, Zou QM. [Progress and challenge of vaccine development against 2019 novel coronavirus (2019-nCoV)] Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 54(0):E029 2020 [PMID: 32234130]
  34. Zhavoronkov A. Geroprotective and senoremediative strategies to reduce the comorbidity, infection rates, severity, and lethality in gerophilic and gerolavic infections Aging 12 2020 [PMID: 32229705]
  35. Vos LM, Bruyndonckx R, Zuithoff NPA, Little P, Oosterheert JJ, Broekhuizen BDL, Lammens C, Loens K, Viveen M, Butler CC, Crook D, Zlateva K, Goossens H, Claas ECJ, Ieven M, Van Loon AM, Verheij TJM, Coenjaerts FEJ. Lower respiratory tract infection in the community: associations between viral aetiology and illness course Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2020 [PMID: 32244051]
  36. Eyal N, Lipsitch M, Smith PG. Human challenge studies to accelerate coronavirus vaccine licensure The Journal of infectious diseases 2020 [PMID: 32232474]
  37. Yan Y, Shin WI, Pang YX, Meng Y, Lai J, You C, Zhao H, Lester E, Wu T, Pang CH. The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment International journal of environmental research and public health 17(7) 2020 [PMID: 32235575]
  38. Agrawal S, Goel AD, Gupta N. Emerging prophylaxis strategies against COVID-19 Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 90(1) 2020 [PMID: 32231348]
  39. Bhatraju PK, Ghassemieh BJ, Nichols M, Kim R, Jerome KR, Nalla AK, Greninger AL, Pipavath S, Wurfel MM, Evans L, Kritek PA, West TE, Luks A, Gerbino A, Dale CR, Goldman JD, O'Mahony S, Mikacenic C. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series The New England journal of medicine 2020 [PMID: 32227758]
  40. Cyranoski D. 'We need to be alert': Scientists fear second coronavirus wave as China's lockdowns ease Nature 2020 [PMID: 32231319]
  41. Yassine HM, Shah Z. How could artificial intelligence aid in the fight against coronavirus? Expert review of anti-infective therapy :1-5 2020 [PMID: 32223349]
  42. Zhang J, Zeng H, Gu J, Li H, Zheng L, Zou Q. Progress and Prospects on Vaccine Development against SARS-CoV-2 Vaccines 8(2) 2020 [PMID: 32235387]
  43. Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19 International journal of antimicrobial agents :105955 2020 [PMID: 32234468]
  44. Li H, Liu SM, Yu XH, Tang SL, Tang CK. Coronavirus disease 2019 (COVID-19): current status and future perspective International journal of antimicrobial agents :105951 2020 [PMID: 32234466]
  45. Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, Kim BT, Kim SJ. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19) Journal of microbiology and biotechnology 30(3):313-324 2020 [PMID: 32238757]
  46. Rahimi F, Talebi Bezmin Abadi A. Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat Archives of medical research 2020 [PMID: 32229157]
  47. Yadav PD, Potdar VA, Choudhary ML, Nyayanit DA, Agrawal M, Jadhav SM, Majumdar TD, Shete-Aich A, Basu A, Abraham P, Cherian SS. Full-genome sequences of the first two SARS-CoV-2 viruses from India The Indian journal of medical research 2020 [PMID: 32242873]
  48. Amirian ES, Levy JK. Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses One health (Amsterdam, Netherlands) 9:100128 2020 [PMID: 32258351]
  49. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G. Virology, Epidemiology, Pathogenesis, and Control of COVID-19 Viruses 12(4) 2020 [PMID: 32230900]
  50. Liu C, Zhou Q, Li Y, Garner LV, Watkins SP, Carter LJ, Smoot J, Gregg AC, Daniels AD, Jervey S, Albaiu D. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases ACS central science 6(3):315-331 2020 [PMID: 32226821]
  51. Rismanbaf A. Potential Treatments for COVID-19; a Narrative Literature Review Archives of academic emergency medicine 8(1):e29 2020 [PMID: 32232214]
  52. Kimpston-Burkgren K, Mora-Díaz JC, Roby P, Bjustrom-Kraft J, Main R, Bosse R, Giménez-Lirola LG. Characterization of the Humoral Immune Response to Porcine Epidemic Diarrhea Virus Infection under Experimental and Field Conditions Using an AlphaLISA Platform Pathogens (Basel, Switzerland) 9(3) 2020 [PMID: 32245150]
  53. Solaimanzadeh I. Acetazolamide, Nifedipine and Phosphodiesterase Inhibitors: Rationale for Their Utilization as Adjunctive Countermeasures in the Treatment of Coronavirus Disease 2019 (COVID-19) Cureus 12(3):e7343 2020 [PMID: 32226695]
  54. Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far Pathogens (Basel, Switzerland) 9(3) 2020 [PMID: 32245083]
  55. Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses Journal of advanced research 24:91-98 2020 [PMID: 32257431]
  56. Yi Y, Lagniton PNP, Ye S, Li E, Xu RH. COVID-19: what has been learned and to be learned about the novel coronavirus disease International journal of biological sciences 16(10):1753-1766 2020 [PMID: 32226295]
  57. Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective International journal of biological sciences 16(10):1708-1717 2020 [PMID: 32226288]
  58. Zhou WK, Wang AL, Xia F, Xiao YN, Tang SY. Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak Mathematical biosciences and engineering : MBE 17(3):2693-2707 2020 [PMID: 32233561]
  59. Shetty AK. Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia Aging and disease 11(2):462-464 2020 [PMID: 32257554]
  60. Zegpi RA, Breedlove C, Gulley S, Toro H. Infectious Bronchitis Virus Immune Responses in the Harderian Gland upon Initial Vaccination Avian diseases 64(1):92-95 2020 [PMID: 32267130]
  61. Zegpi RA, Joiner KS, van Santen VL, Toro H. Infectious Bronchitis Virus Population Structure Defines Immune Response and Protection Avian diseases 64(1):60-68 2020 [PMID: 32267126]
  62. Zegpi RA, He L, Yu Q, Joiner KS, van Santen VL, Toro H. Limited Protection Conferred by Recombinant Newcastle Disease Virus Expressing Infectious Bronchitis Spike Protein Avian diseases 64(1):53-59 2020 [PMID: 32267125]
  63. Wang N, Shang J, Jiang S, Du L. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses Frontiers in microbiology 11:298 2020 [PMID: 32265848]
  64. Zaher KS, El-Dabae WH, El-Sebelgy MM, Aly NI, Salama ZT. Genotyping and phylogenetic analysis of canine parvovirus circulating in Egypt Veterinary world 13(2):326-333 2020 [PMID: 32255975]
  65. Andreeva A, Nikolaeva O, Altynbekov O, Galieva C, Ilina K. Influence of interferon-based drugs on immunological indices in specific prevention Veterinary world 13(2):238-244 2020 [PMID: 32255964]

Eastern equine encephalitis virus

  1. Chen CL, Hasan SS, Klose T, Sun Y, Buda G, Sun C, Klimstra WB, Rossmann MG. Cryo-EM structure of eastern equine encephalitis virus in complex with heparan sulfate analogues Proceedings of the National Academy of Sciences of the United States of America 2020 [PMID: 32245806]

Ebola virus

  1. Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection Journal of biological regulators and homeostatic agents 34(2) 2020 [PMID: 32253888]
  2. Ollmann Saphire E. A Vaccine against Ebola Virus Cell 181(1):6 2020 [PMID: 32243796]
  3. Rutten L, Gilman MSA, Blokland S, Juraszek J, McLellan JS, Langedijk JPM. Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers Cell reports 30(13):4540-4550.e3 2020 [PMID: 32234486]
  4. Md Insiat Islam Rabby. Current Drugs with Potential for Treatment of COVID-19: A Literature Review Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 23(1):58-64 2020 [PMID: 32251618]
  5. Hassan MZ, Ahmed MS, Khan MM, Uddin MA, Chowdhury F, Kamruzzaman M. Genomic profiling of Nipah virus using NGS driven RNA-Seq expression data Bioinformation 15(12):853-862 2019 [PMID: 32256005]
  6. Terracciano E, Amadori F, Zaratti L, Franco E. [Old outbreaks and new vaccines: Italy facing Ebola] Igiene e sanita pubblica 75(6):487-493 2019 [PMID: 32242171]

Escherichia coli

  1. Liu G, Qiao X, Chang C, Hua T, Wang J, Tang B, Zhang D. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2 Viral immunology 2020 [PMID: 32255758]
  2. Zhang J, Luo Y, Poh CL. Blue Light-Directed Cell Migration, Aggregation, and Patterning Journal of molecular biology 2020 [PMID: 32247761]
  3. Kiefer MC, Motyka NI, Clements JD, Bitoun JP. Enterotoxigenic Escherichia coli Heat-Stable Toxin Increases the Rate of Zinc Release from Metallothionein and Is a Zinc- and Iron-Binding Peptide mSphere 5(2) 2020 [PMID: 32238569]
  4. Lamazares E, Gutiérrez F, Hidalgo A, Gutiérrez NA, Espinoza FI, Sánchez O, Cortez-San Martín M, Mascayano C, González J, Saavedra J, Altamirano C, Mansur M, Ruiz Á, Toledo JR. A Heterologous Viral Protein Scaffold for Chimeric Antigen Design: An Example PCV2 Virus Vaccine Candidate Viruses 12(4) 2020 [PMID: 32244384]
  5. Uwase J, Chu R, Kassegne K, Lei Y, Shen F, Fu H, Sun Y, Xuan Y, Cao J, Cheng Y. Immunogenicity analysis of conserved fragments in Plasmodium ovale species merozoite surface protein 4 Malaria journal 19(1):126 2020 [PMID: 32228600]
  6. Medeiros PHQS, Bolick DT, Ledwaba SE, Kolling GL, Costa DVS, Oriá RB, Lima AÂM, Barry EM, Guerrant RL. A bivalent vaccine confers immunogenicity and protection against <i>Shigella flexneri</i> and enterotoxigenic <i>Escherichia coli</i> infections in mice NPJ vaccines 5:30 2020 [PMID: 32257392]
  7. Deng G, Zhang W, Ji N, Zhai Y, Shi X, Liu X, Yang S. Identification of Secreted O-Mannosylated Proteins From BCG and Characterization of Immunodominant Antigens BCG_0470 and BCG_0980 Frontiers in microbiology 11:407 2020 [PMID: 32231652]

Francisella tularensis (Tularemia)

  1. Cunningham AL, Mann BJ, Qin A, Santiago AE, Grassel C, Lipsky M, Vogel SN, Barry EM. Characterization of Schu S4 <i>aro</i> mutants as live attenuated tularemia vaccine candidates Virulence 11(1):283-294 2020 [PMID: 32241221]
  2. Hassan MZ, Ahmed MS, Khan MM, Uddin MA, Chowdhury F, Kamruzzaman M. Genomic profiling of Nipah virus using NGS driven RNA-Seq expression data Bioinformation 15(12):853-862 2019 [PMID: 32256005]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Wang Q, Ma B, Liang Q, Zhu A, Wang H, Fu L, Han X, Shi X, Xiang Y, Shang H, Zhang L. Stabilized diverse HIV-1 envelope trimers for vaccine design Emerging microbes & infections 9(1):775-786 2020 [PMID: 32241249]
  2. Gorman J, Chuang GY, Lai YT, Shen CH, Boyington JC, Druz A, Geng H, Louder MK, McKee K, Rawi R, Verardi R, Yang Y, Zhang B, Doria-Rose NA, Lin B, Moore PL, Morris L, Shapiro L, Mascola JR, Kwong PD. Structure of Super-Potent Antibody CAP256-VRC26.25 in Complex with HIV-1 Envelope Reveals a Combined Mode of Trimer-Apex Recognition Cell reports 31(1):107488 2020 [PMID: 32268107]
  3. Roy A, Basak S. HIV long-term non-progressors share similar features with simian immunodeficiency virus infection of chimpanzees Journal of biomolecular structure & dynamics :1-8 2020 [PMID: 32223527]
  4. Vila-Corcoles A, Ochoa-Gondar O, Vila-Rovira A, Aragon M, Esteban-Julvez L, Chamorro N, Hospital I, Satue E, Blade J, de Diego C, Gomez-Bertomeu F, Raga X. Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study Lung 2020 [PMID: 32253492]
  5. Bhardwaj P, Bhatia E, Sharma S, Ahamad N, Banerjee R. Advancements in Prophylactic and Therapeutic Nanovaccines Acta biomaterialia 2020 [PMID: 32268235]
  6. Niessl J, Baxter AE, Morou A, Brunet-Ratnasingham E, Sannier G, Gendron-Lepage G, Richard J, Delgado GG, Brassard N, Turcotte I, Fromentin R, Bernard NF, Chomont N, Routy JP, Dubé M, Finzi A, Kaufmann DE. Persistent expansion and Th1-like skewing of HIV-specific circulating T follicular helper cells during antiretroviral therapy EBioMedicine 54:102727 2020 [PMID: 32268275]
  7. Groome MJ, Fairlie L, Morrison J, Fix A, Koen A, Masenya M, Jose L, Madhi SA, Page N, McNeal M, Dally L, Cho I, Power M, Flores J, Cryz S. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial The Lancet. Infectious diseases 2020 [PMID: 32251641]
  8. Dong Y, Wang L, Burgner DP, Miller JE, Song Y, Ren X, Li Z, Xing Y, Ma J, Sawyer SM, Patton GC. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017 BMJ (Clinical research ed.) 369:m1043 2020 [PMID: 32241761]
  9. Mothe B, Brander C. Small steps forward for HIV vaccine development Nature medicine 2020 [PMID: 32242125]
  10. Latner DR, Sowers SB, Anthony K, Colley H, Badeau C, Coates J, Wong P, Fakile Y, Interiano C, Pannell KB, Leung-Pineda V, Patel MM, Rota PA, Limbago BM, Hickman CJ. Qualitative Variation Among Commercial Immunoassays to Detect Measles-Specific IgG Journal of clinical microbiology 2020 [PMID: 32238434]
  11. Sweeney S, Vassall A, Guinness L, Siapka M, Chimbindi N, Mudzengi D, Gomez GB. Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa PharmacoEconomics 2020 [PMID: 32239479]
  12. Alving CR, Peachman KK, Matyas GR, Rao M, Beck Z. Army Liposome Formulation (ALF) family of vaccine adjuvants Expert review of vaccines :1-14 2020 [PMID: 32228108]
  13. Kumar GS, Pezzi C, Wien S, Mamo B, Scott K, Payton C, Urban K, Hughes S, Kennedy L, Cabanting N, Montour J, Titus M, Aguirre J, Kawasaki B, Ford R, Jentes ES. Health of Special Immigrant Visa holders from Iraq and Afghanistan after arrival into the United States using Domestic Medical Examination data, 2014-2016: A cross-sectional analysis PLoS medicine 17(3):e1003083 2020 [PMID: 32231361]
  14. David P, Drabczyk-Pluta M, Pastille E, Knuschke T, Werner T, Honke N, Megger DA, Akhmetzyanova I, Shaabani N, Eyking-Singer A, Cario E, Kershaw O, Gruber AD, Tenbusch M, Dietze KK, Trilling M, Liu J, Schadendorf D, Streeck H, Lang KS, Xie Y, Zimmer L, Sitek B, Paschen A, Westendorf AM, Dittmer U, Zelinskyy G. Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology PLoS pathogens 16(3):e1008340 2020 [PMID: 32226027]
  15. Kazer SW, Aicher TP, Muema DM, Carroll SL, Ordovas-Montanes J, Miao VN, Tu AA, Ziegler CGK, Nyquist SK, Wong EB, Ismail N, Dong M, Moodley A, Berger B, Love JC, Dong KL, Leslie A, Ndhlovu ZM, Ndung'u T, Walker BD, Shalek AK. Integrated single-cell analysis of multicellular immune dynamics during hyperacute HIV-1 infection Nature medicine 2020 [PMID: 32251406]
  16. Colby DJ, Sarnecki M, Barouch DH, Tipsuk S, Stieh DJ, Kroon E, Schuetz A, Intasan J, Sacdalan C, Pinyakorn S, Grandin P, Song H, Tovanabutra S, Shubin Z, Kim D, Paquin-Proulx D, Eller MA, Thomas R, de Souza M, Wieczorek L, Polonis VR, Pagliuzza A, Chomont N, Peter L, Nkolola JP, Vingerhoets J, Truyers C, Pau MG, Schuitemaker H, Phanuphak N, Michael N, Robb ML, Tomaka FL, Ananworanich J. Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption Nature medicine 2020 [PMID: 32235883]
  17. Rosás-Umbert M, Ruiz-Riol M, Fernández MA, Marszalek M, Coll P, Manzardo C, Cedeño S, Miró JM, Clotet B, Hanke T, Moltó J, Mothe B, Brander C. <i>In vivo</i> Effects of Romidepsin on T-Cell Activation, Apoptosis and Function in the BCN02 HIV-1 Kick&amp;Kill Clinical Trial Frontiers in immunology 11:418 2020 [PMID: 32265913]
  18. Cong Z, Tong L, Wang Y, Su A, Chen T, Wei Q, Xue J, Qin C. Does Mucosal B1 Activation Result in the Accumulation of Peak IgM During Chronic Intrarectal SIVmac239 Exposure to Protect Chinese-Origin Rhesus Macaques From Disease Progression? Frontiers in microbiology 11:357 2020 [PMID: 32265850]
  19. Cai CX, Schneck NA, Ivleva VB, Gulla K, Zhang Y, Gowetski D, Paula Lei Q. Quantification of residual hydrophobic fusion peptide with monomer and dimer forms using reversed-phase liquid chromatography Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 1144:122073 2020 [PMID: 32224438]
  20. Sobieszczyk ME. Therapeutic HIV vaccines and broadly neutralizing antibodies Topics in antiviral medicine 27(4):97-9101 2020 [PMID: 32224500]
  21. Goga A, Feucht U, Zar HJ, Vanker A, Wiysonge CS, McKerrow N, Wright CY, Loveday M, Odendaal W, Ramokolo V, Ramraj T, Bamford L, Green RJ, Pillay Y, Nannan N. Neonatal, infant and child health in South Africa: Reflecting on the past towards a better future South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 109(11b):83-88 2019 [PMID: 32252874]
  22. Gray G, Doherty T, Mohapi L, Coetzee J, Hopkins KL, Malahleha M, Lazarus E, Dietrich J, Pillay-van Wyk V, Laher F. HIV research in South Africa: Advancing life South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 109(11b):36-40 2019 [PMID: 32252866]
  23. Garces F. The path toward an HIV-1 vaccine Porto biomedical journal 2(5):150-152 2017 [PMID: 32258610]

Lassa virus

  1. Berrie DM, Waters RC, Montoya C, Chatel A, Vela EM. Development of a high-yield live-virus vaccine production platform using a novel fixed-bed bioreactor Vaccine 2020 [PMID: 32247568]
  2. Ibukun FI. Inter-Lineage Variation of Lassa Virus Glycoprotein Epitopes: A Challenge to Lassa Virus Vaccine Development Viruses 12(4) 2020 [PMID: 32244402]

Marburg virus

  1. Rutten L, Gilman MSA, Blokland S, Juraszek J, McLellan JS, Langedijk JPM. Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers Cell reports 30(13):4540-4550.e3 2020 [PMID: 32234486]

Mycobacterium tuberculosis (tuberculosis)

  1. Suliman S, Gela A, Mendelsohn SC, Iwany SK, Tamara KL, Mabwe S, Bilek N, Darboe F, Fisher M, Corbett AJ, Kjer-Nielsen L, Eckle SBG, Huang CC, Zhang Z, Lewinsohn DM, McCluskey J, Rossjohn J, Hatherill M, León SR, Calderon RI, Lecca L, Murray M, Scriba TJ, Van Rhijn I, Moody DB. Peripheral blood mucosal-associated invariant T (MAIT) cells in tuberculosis patients and healthy Mycobacterium tuberculosis-exposed controls The Journal of infectious diseases 2020 [PMID: 32267943]
  2. Bhardwaj P, Bhatia E, Sharma S, Ahamad N, Banerjee R. Advancements in Prophylactic and Therapeutic Nanovaccines Acta biomaterialia 2020 [PMID: 32268235]
  3. Dong Y, Wang L, Burgner DP, Miller JE, Song Y, Ren X, Li Z, Xing Y, Ma J, Sawyer SM, Patton GC. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017 BMJ (Clinical research ed.) 369:m1043 2020 [PMID: 32241761]
  4. Tarancón R, Domínguez-Andrés J, Uranga S, Ferreira AV, Groh LA, Domenech M, González-Camacho F, Riksen NP, Aguilo N, Yuste J, Martín C, Netea MG. New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia PLoS pathogens 16(4):e1008404 2020 [PMID: 32240273]
  5. Sweeney S, Vassall A, Guinness L, Siapka M, Chimbindi N, Mudzengi D, Gomez GB. Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa PharmacoEconomics 2020 [PMID: 32239479]
  6. Kumar GS, Pezzi C, Wien S, Mamo B, Scott K, Payton C, Urban K, Hughes S, Kennedy L, Cabanting N, Montour J, Titus M, Aguirre J, Kawasaki B, Ford R, Jentes ES. Health of Special Immigrant Visa holders from Iraq and Afghanistan after arrival into the United States using Domestic Medical Examination data, 2014-2016: A cross-sectional analysis PLoS medicine 17(3):e1003083 2020 [PMID: 32231361]
  7. Harris LD, Khayumbi J, Ongalo J, Sasser LE, Tonui J, Campbell A, Odhiambo FH, Ouma SG, Alter G, Gandhi NR, Day CL. Distinct Human NK Cell Phenotypes and Functional Responses to <i>Mycobacterium tuberculosis</i> in Adults From TB Endemic and Non-endemic Regions Frontiers in cellular and infection microbiology 10:120 2020 [PMID: 32266170]
  8. Deng G, Zhang W, Ji N, Zhai Y, Shi X, Liu X, Yang S. Identification of Secreted O-Mannosylated Proteins From BCG and Characterization of Immunodominant Antigens BCG_0470 and BCG_0980 Frontiers in microbiology 11:407 2020 [PMID: 32231652]
  9. Goga A, Feucht U, Zar HJ, Vanker A, Wiysonge CS, McKerrow N, Wright CY, Loveday M, Odendaal W, Ramokolo V, Ramraj T, Bamford L, Green RJ, Pillay Y, Nannan N. Neonatal, infant and child health in South Africa: Reflecting on the past towards a better future South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 109(11b):83-88 2019 [PMID: 32252874]

Nipah virus

  1. Hassan MZ, Ahmed MS, Khan MM, Uddin MA, Chowdhury F, Kamruzzaman M. Genomic profiling of Nipah virus using NGS driven RNA-Seq expression data Bioinformation 15(12):853-862 2019 [PMID: 32256005]

Plasmodium falciparum (Malaria)

  1. Conti P, Younes A. Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection Journal of biological regulators and homeostatic agents 34(2) 2020 [PMID: 32253888]
  2. Li D, Yu C, Guo J, Wang Y, Zhao Y, Wang L, Soe MT, Feng H, Kyaw MP, Sattabongkot J, Jiang L, Cui L, Zhu X, Cao Y. Plasmodium vivax HAP2/GCS1 gene exhibits limited genetic diversity among parasite isolates from the Greater Mekong Subregion Parasites & vectors 13(1):175 2020 [PMID: 32264948]
  3. Arisue N, Palacpac NMQ, Tougan T, Horii T. Characteristic features of the SERA multigene family in the malaria parasite Parasites & vectors 13(1):170 2020 [PMID: 32252804]
  4. Aerts C, Revilla M, Duval L, Paaijmans K, Chandrabose J, Cox H, Sicuri E. Understanding the role of disease knowledge and risk perception in shaping preventive behavior for selected vector-borne diseases in Guyana PLoS neglected tropical diseases 14(4):e0008149 2020 [PMID: 32251455]
  5. Bhardwaj P, Bhatia E, Sharma S, Ahamad N, Banerjee R. Advancements in Prophylactic and Therapeutic Nanovaccines Acta biomaterialia 2020 [PMID: 32268235]
  6. Torrado JJ, Serrano DR, Capilla J. Antifungal and Antiparasitic Drug Delivery Pharmaceutics 12(4) 2020 [PMID: 32260348]
  7. Dong Y, Wang L, Burgner DP, Miller JE, Song Y, Ren X, Li Z, Xing Y, Ma J, Sawyer SM, Patton GC. Infectious diseases in children and adolescents in China: analysis of national surveillance data from 2008 to 2017 BMJ (Clinical research ed.) 369:m1043 2020 [PMID: 32241761]
  8. Alkema M, Reuling IJ, de Jong GM, Lanke K, Coffeng LE, van Gemert GJ, van de Vegte-Bolmer M, de Mast Q, van Crevel R, Ivinson K, Ockenhouse CF, McCarthy JS, Sauerwein R, Collins KA, Bousema T. A randomized clinical trial to compare P. falciparum gametocytaemia and infectivity following blood-stage or mosquito bite induced controlled malaria infection The Journal of infectious diseases 2020 [PMID: 32239171]
  9. Zhang H, Xi Q, Huang S, Zheng L, Yang W, Zuo Y. iSP-RAAC: Identify secretory proteins of malaria parasite using reduced amino acid composition Combinatorial chemistry & high throughput screening 2020 [PMID: 32238133]
  10. Alving CR, Peachman KK, Matyas GR, Rao M, Beck Z. Army Liposome Formulation (ALF) family of vaccine adjuvants Expert review of vaccines :1-14 2020 [PMID: 32228108]
  11. Kurtovic L, Atre T, Feng G, Wines BD, Chan JA, Boyle MJ, Drew DR, Hogarth PM, Fowkes FJI, Bergmann-Leitner ES, Beeson JG. Multi-functional antibodies are induced by the RTS,S malaria vaccine and associated with protection in a phase I/IIa trial The Journal of infectious diseases 2020 [PMID: 32236404]
  12. Feldstein LR, Bennett SD, Estivariz CF, Cooley GM, Weil L, Billah MM, Uzzaman MS, Bohara R, Vandenent M, Adhikari JM, Leidman E, Hasan M, Akhtar S, Hasman A, Conklin L, Ehlman D, Alamgir A, Flora MS. Vaccination coverage survey and seroprevalence among forcibly displaced Rohingya children, Cox's Bazar, Bangladesh, 2018: A cross-sectional study PLoS medicine 17(3):e1003071 2020 [PMID: 32231368]
  13. Kumar GS, Pezzi C, Wien S, Mamo B, Scott K, Payton C, Urban K, Hughes S, Kennedy L, Cabanting N, Montour J, Titus M, Aguirre J, Kawasaki B, Ford R, Jentes ES. Health of Special Immigrant Visa holders from Iraq and Afghanistan after arrival into the United States using Domestic Medical Examination data, 2014-2016: A cross-sectional analysis PLoS medicine 17(3):e1003083 2020 [PMID: 32231361]
  14. Rollier CS, Spencer AJ, Sogaard KC, Honeycutt J, Furze J, Bregu M, Gilbert SC, Wyllie D, Hill AVS. Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule Scientific reports 10(1):5716 2020 [PMID: 32235848]
  15. Uwase J, Chu R, Kassegne K, Lei Y, Shen F, Fu H, Sun Y, Xuan Y, Cao J, Cheng Y. Immunogenicity analysis of conserved fragments in Plasmodium ovale species merozoite surface protein 4 Malaria journal 19(1):126 2020 [PMID: 32228600]
  16. Harmsen C, Turner L, Thrane S, Sander AF, Theander TG, Lavstsen T. Immunization with virus-like particles conjugated to CIDRα1 domain of Plasmodium falciparum erythrocyte membrane protein 1 induces inhibitory antibodies Malaria journal 19(1):132 2020 [PMID: 32228596]
  17. Shah Z, Adams M, Moser KA, Shrestha B, Stucke EM, Laufer MK, Serre D, Silva JC, Takala-Harrison S. Optimization of parasite DNA enrichment approaches to generate whole genome sequencing data for Plasmodium falciparum from low parasitaemia samples Malaria journal 19(1):135 2020 [PMID: 32228559]
  18. Arévalo-Pinzón G, Garzón-Ospina D, Pulido FA, Bermúdez M, Forero-Rodríguez J, Rodríguez-Mesa XM, Reyes-Guarín LP, Suárez CF, Patarroyo MA. <i>Plasmodium vivax</i> Cell Traversal Protein for Ookinetes and Sporozoites (CelTOS) Functionally Restricted Regions Are Involved in Specific Host-Pathogen Interactions Frontiers in cellular and infection microbiology 10:119 2020 [PMID: 32266169]
  19. Dos Santos RO, da Cruz MGS, Lopes SCP, Oliveira LB, Nogueira PA, Lima ES, Soares IS, Kano FS, de Carvalho AT, Costa FTM, Ganoza CA, de Lacerda MVG, Lalwani P. A First <i>Plasmodium vivax</i> Natural Infection Induces Increased Activity of the Interferon Gamma-Driven Tryptophan Catabolism Pathway Frontiers in microbiology 11:400 2020 [PMID: 32256470]
  20. Guan H, Peng J, Jiang L, Mo G, Li X, Peng X. CD19<sup>+</sup>CD1d<sup>hi</sup>CD5<sup>hi</sup> B Cells Can Downregulate Malaria ITV Protection by IL-10 Secretion Frontiers in public health 8:77 2020 [PMID: 32257991]
  21. Finale E, Ferrero P, Andorno S, De Simone A, Ponili A, Borraccino A, Guala A. Malaria in pediatric age in the Piedmont Region Annali dell'Istituto superiore di sanita 56(1):72-75 2020 [PMID: 32242538]
  22. Md Insiat Islam Rabby. Current Drugs with Potential for Treatment of COVID-19: A Literature Review Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 23(1):58-64 2020 [PMID: 32251618]

Salmonella

  1. Tack B, Phoba MF, Barbé B, Kalonji LM, Hardy L, Van Puyvelde S, Ingelbeen B, Falay D, Ngbonda D, van der Sande MAB, Deborggraeve S, Jacobs J, Lunguya O. Non-typhoidal Salmonella bloodstream infections in Kisantu, DR Congo: Emergence of O5-negative Salmonella Typhimurium and extensive drug resistance PLoS neglected tropical diseases 14(4):e0008121 2020 [PMID: 32240161]
  2. Liu PY, Wang KC, Hong YP, Chen BH, Shi ZY, Chiou CS. The first imported case of extensively drug-resistant Salmonella enterica serotype Typhi infection in Taiwan and the antimicrobial therapy Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2020 [PMID: 32253142]
  3. Guard J, Rothrock M, Jones D, Gast R. Low Dose Infection of Hens in Lay with <i>Salmonella enterica</i> Serovar Enteritidis from Different Genomic Clades Avian diseases 64(1):7-15 2020 [PMID: 32267120]

Shigella

  1. Raso MM, Gasperini G, Alfini R, Schiavo F, Aruta MG, Carducci M, Forgione MC, Martini S, Cescutti P, Necchi F, Micoli F. GMMA and Glycoconjugate Approaches Compared in Mice for the Development of a Vaccine against <i>Shigella flexneri</i> Serotype 6 Vaccines 8(2) 2020 [PMID: 32260067]
  2. Medeiros PHQS, Bolick DT, Ledwaba SE, Kolling GL, Costa DVS, Oriá RB, Lima AÂM, Barry EM, Guerrant RL. A bivalent vaccine confers immunogenicity and protection against <i>Shigella flexneri</i> and enterotoxigenic <i>Escherichia coli</i> infections in mice NPJ vaccines 5:30 2020 [PMID: 32257392]

Variola major (Smallpox)

  1. Jacobson RM, St Sauver JL, Griffin JM, MacLaughlin KL, Finney Rutten LJ. How health care providers should address vaccine hesitancy in the clinical setting: Evidence for presumptive language in making a strong recommendation Human vaccines & immunotherapeutics :1-5 2020 [PMID: 32242766]
  2. O'Connell CM, Jasperse B, Hagen CJ, Titong A, Verardi PH. Replication-inducible vaccinia virus vectors with enhanced safety in vivo PloS one 15(4):e0230711 2020 [PMID: 32240193]

Click HERE to see the publications in the last month.